Table of Contents Author Guidelines Submit a Manuscript
Journal of Thyroid Research
Volume 2016 (2016), Article ID 2454989, 7 pages
http://dx.doi.org/10.1155/2016/2454989
Research Article

Hypothyroidism in Pancreatic Cancer: Role of Exogenous Thyroid Hormone in Tumor Invasion—Preliminary Observations

1Departments of Surgery, Jefferson Pancreatic, Biliary and Related Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA
2Department of Biomedical Sciences, University of New England, Biddeford, ME 04005, USA

Received 5 October 2015; Revised 15 March 2016; Accepted 16 March 2016

Academic Editor: Noriyuki Koibuchi

Copyright © 2016 Konrad Sarosiek et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. F. Hezel, A. C. Kimmelman, B. Z. Stanger, N. Bardeesy, and R. A. Depinho, “Genetics and biology of pancreatic ductal adenocarcinoma,” Genes and Development, vol. 20, no. 10, pp. 1218–1249, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Jemal, R. Siegel, E. Ward et al., “Cancer statistics, 2008,” CA: A Cancer Journal for Clinicians, vol. 58, no. 2, pp. 71–96, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. G. A. Brent, “The molecular basis of thyroid hormone action,” The New England Journal of Medicine, vol. 331, no. 13, pp. 847–853, 1994. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Aoki, R. M. Belin, R. Clickner, R. Jeffries, L. Phillips, and K. R. Mahaffey, “Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999–2002),” Thyroid, vol. 17, no. 12, pp. 1211–1223, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. I. M. Bensenor, R. D. Olmos, and P. A. Lotufo, “Hypothyroidism in the elderly: diagnosis and management,” Clinical Interventions in Aging, vol. 7, pp. 97–111, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. A. R. Cappola, L. P. Fried, A. M. Arnold et al., “Thyroid status, cardiovascular risk, and mortality in older adults,” The Journal of the American Medical Association, vol. 295, no. 9, pp. 1033–1041, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Gussekloo, E. Van Exel, A. J. M. de Craen, A. E. Meinders, M. Frölich, and R. G. J. Westendorp, “Thyroid status, disability and cognitive function, and survival in old age,” The Journal of the American Medical Association, vol. 292, no. 21, pp. 2591–2599, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. I. M. Benseñor, A. C. Goulart, P. A. Lotufo, P. R. Menezes, and M. Scazufca, “Prevalence of thyroid disorders among older people: results from the São Paulo Ageing & Health Study,” Cadernos de Saúde Pública, vol. 27, no. 1, pp. 155–161, 2011. View at Google Scholar
  9. C. C. Kapdi and J. N. Wolfe, “Breast cancer. Relationship to thyroid supplements for hypothyroidism.,” Journal of the American Medical Association, vol. 236, no. 10, pp. 1124–1127, 1976. View at Publisher · View at Google Scholar · View at Scopus
  10. M. B. Goldman, R. R. Monson, and F. Maloof, “Cancer mortality in women with thyroid disease,” Cancer Research, vol. 50, no. 8, pp. 2283–2289, 1990. View at Google Scholar · View at Scopus
  11. C. Giani, P. Fierabracci, R. Bonacci et al., “Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy,” Journal of Clinical Endocrinology and Metabolism, vol. 81, no. 3, pp. 990–994, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. J. L. P. Kuijpens, I. Nyklíčtek, M. W. J. Louwman, T. A. P. Weetman, V. J. M. Pop, and J.-W. W. Coebergh, “Hypothyroidism might be related to breast cancer in post-menopausal women,” Thyroid, vol. 15, no. 11, pp. 1253–1259, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Rennert, H. S. Rennert, M. Pinchev, and S. B. Gruber, “A case-control study of levothyroxine and the risk of colorectal cancer,” Journal of the National Cancer Institute, vol. 102, no. 8, pp. 568–572, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Iishi, M. Tatsuta, M. Baba, R. Yamamoto, and H. Taniguchi, “Enhancement by thyroxine of gastric carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine in Wistar rats,” British Journal of Cancer, vol. 68, no. 3, pp. 515–518, 1993. View at Publisher · View at Google Scholar · View at Scopus
  15. L. C. Hall, E. P. Salazar, S. R. Kane, and N. Liu, “Effects of thyroid hormones on human breast cancer cell proliferation,” Journal of Steroid Biochemistry and Molecular Biology, vol. 109, no. 1-2, pp. 57–66, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. M.-L. Hsieh and H.-H. Juang, “Cell growth effects of triiodothyronine and expression of thyroid hormone receptor in prostate carcinoma cells,” Journal of Andrology, vol. 26, no. 3, pp. 422–428, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Sarosiek, E. Jones, G. Chipitsyna et al., “Osteopontin (OPN) isoforms, diabetes, obesity, and cancer; what is one got to do with the other? a new role for opn,” Journal of Gastrointestinal Surgery, vol. 19, no. 4, pp. 639–650, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Aranda, O. Martínez-Iglesias, L. Ruiz-Llorente, V. García-Carpizo, and A. Zambrano, “Thyroid receptor: roles in cancer,” Trends in Endocrinology and Metabolism, vol. 20, no. 7, pp. 318–324, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Ellis, K. Cohen, E. S. H. Maman, A. Hercbergs, P. J. Davis, and O. Ashur-Fabian, “THE involvement of thyroid hormones in cancer,” Harefuah, vol. 154, no. 8, pp. 512–540, 2015. View at Google Scholar · View at Scopus
  20. A. H. Hercbergs, O. Ashur-Fabian, and D. Garfield, “Thyroid hormones and cancer: clinical studies of hypothyroidism in oncology,” Current Opinion in Endocrinology, Diabetes and Obesity, vol. 17, no. 5, pp. 432–436, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. L. C. Moeller and D. Führer, “Thyroid hormone, thyroid hormone receptors, and cancer: a clinical perspective,” Endocrine-Related Cancer, vol. 20, no. 2, pp. R19–R29, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. A. M. Mondul, S. J. Weinstein, T. Bosworth, A. T. Remaley, J. Virtamo, and D. Albanes, “Circulating thyroxine, thyroid-stimulating hormone, and hypothyroid status and the risk of prostate cancer,” PLoS ONE, vol. 7, no. 10, Article ID e47730, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Liebig, G. Ayala, J. A. Wilks, D. H. Berger, and D. J. Albo, “Perineural invasion in cancer: a review of the literature,” Cancer, vol. 115, no. 15, pp. 3379–3391, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. I. E. Demir, G. O. Ceyhan, F. Liebl, J. G. D'Haese, M. Maak, and H. Friess, “Neural invasion in pancreatic cancer: the past, present and future,” Cancers, vol. 2, no. 3, pp. 1513–1527, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. S. J. Conde, R. A. M. Luvizotto, M. T. Sibio, M. L. H. Katayama, M. M. Brentani, and C. R. Nogueira, “Tamoxifen inhibits transforming growth factor-α gene expression in human breast carcinoma samples treated with triiodothyronine,” Journal of Endocrinological Investigation, vol. 31, no. 12, pp. 1047–1051, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. H.-Y. Tang, H.-Y. Lin, S. Zhang, F. B. Davis, and P. J. Davis, “Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor,” Endocrinology, vol. 145, no. 7, pp. 3265–3272, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. F. B. Davis, H.-Y. Tang, A. Shih et al., “Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells,” Cancer Research, vol. 66, no. 14, pp. 7270–7275, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. K.-H. Tsui, W.-C. Hsieh, M.-H. Lin, P.-L. Chang, and H.-H. Juang, “Triiodothyronine modulates cell proliferation of human prostatic carcinoma cells by downregulation of the B-cell translocation gene 2,” Prostate, vol. 68, no. 6, pp. 610–619, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. C.-C. Yen, Y.-H. Huang, C.-Y. Liao et al., “Mediation of the inhibitory effect of thyroid hormone on proliferation of hepatoma cells by transforming growth factor-beta,” Journal of Molecular Endocrinology, vol. 36, no. 1, pp. 9–21, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. R.-N. Chen, Y.-H. Huang, Y.-C. Lin et al., “Thyroid hormone promotes cell invasion through activation of furin expression in human hepatoma cell lines,” Endocrinology, vol. 149, no. 8, pp. 3817–3831, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Liu, Z. Li, S. Bai et al., “Mechanism of cancer cell adaptation to metabolic stress: proteomics identification of a novel thyroid hormone-mediated gastric carcinogenenic signaling pathway,” Molecular and Cellular Proteomics, vol. 8, no. 1, pp. 70–85, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. H.-Y. Lin, H.-Y. Tang, A. Shih et al., “Thyroid hormone is a MAPK-dependent growth factor for thyroid cancer cells and is anti-apoptotic,” Steroids, vol. 72, no. 2, pp. 180–187, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. H.-Y. Lin, M. Sun, H.-Y. Tang et al., “L-thyroxine vs. 3,5,3′-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase,” American Journal of Physiology-Cell Physiology, vol. 296, no. 5, pp. C980–C991, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Cohen, M. Ellis, S. Khoury, P. J. Davis, A. Hercbergs, and O. Ashur-Fabian, “Thyroid hormone is a MAPK-dependent growth factor for human myeloma cells acting via αvβ3 integrin,” Molecular Cancer Research, vol. 9, no. 10, pp. 1385–1394, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Pinto, P. Soares, and D. Ribatti, “Thyroid hormone as a regulator of tumor induced angiogenesis,” Cancer Letters, vol. 301, no. 2, pp. 119–126, 2011. View at Publisher · View at Google Scholar
  36. S. Dinda, A. Sanchez, and V. Moudgil, “Estrogen-like effects of thyroid hormone on the regulation of tumor suppressor proteins, p53 and retinoblastoma, in breast cancer cells,” Oncogene, vol. 21, no. 5, pp. 761–768, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Otto and J. Fandrey, “Thyroid hormone induces hypoxia-inducible factor 1α gene expression through thyroid hormone receptor β/retinoid X receptor α-dependent activation of hepatic leukemia factor,” Endocrinology, vol. 149, no. 5, pp. 2241–2250, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Hercbergs, R. E. Johnson, O. Ashur-Jabian et al., “Medically induced euthyroid hypothyroxinemia may extend survival in compassionate need cancer patients: an observational study,” Oncologist, vol. 20, no. 1, pp. 72–76, 2015. View at Publisher · View at Google Scholar · View at Scopus